Gene Expression Changes In Young and Geriatric Skin

Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age21+
SponsorWright State University

About this trial

This study does not involve any particular diagnosis. The goal of this research study is to explore the effects of artificial sunlight (ultraviolet B radiation; UVB) on the skin of young adults versus geriatric adults. Sunlight exerts many effects on the body. There is evidence that in response to ultraviolet B radiation (UVB), which are the burning rays of sunlight, young adult skin responds differently than geriatric skin. In fact, researchers feel that this difference in how the skin reacts to UVB is why skin cancers are found in older skin. Researchers believe that a major difference between young adult and geriatric skin is that young skin has a lot of a protein called insulin-like growth factor-1 (IGF-1), whereas geriatric skin has very little. The current study will test how young adult versus geriatric skin responds to UVB, and if geriatric skin treated with an injection of small amount of IGF-1 drug will then act like young skin.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Male/Female

White skin (Fitzpatrick types I and II)

Age 21-30 or 65 and older

Able to comprehend procedures/risks

Disqualifiers

Known photosensitivity

Currently on photosensitizing medications

Diabetes Mellitus

History of abnormal scarring

Trial design

Design model

Parallel

Treatments tested in this trial

  • Insulin-Like Growth Factor 1

    Drug

    Growth factor protein

  • No Insulin-Lie Growth Factor 1

    Other intervention

    No Insulin-Like Growth Factor 1 will be given.

Treatment groups

24 Participants
are divided into 2 treatment groups
Group A: Young AdultPlacebo comparator 1 intervention
Group B: Geriatric AdultActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in expression genes involved in protecting skin cells from UVB damage in younger skin and geriatric skin injected with IGF-1 from baseline

Expression genes involved in protecting skin cells from UVB damage, including p21, xeroderma pigmentosum (XPC), and polymerase eta, will be higher following UVB exposure in younger skin and geriatric skin injected with IGF-1 than in geriatric skin injected with saline as a control.

Time frame
2 Days

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.